SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) May 15, 2003
CompuMed, Inc.
(Exact name of registrant as specified in its charter)
Delaware (State or other jurisdiction of incorporation) |
0-14210 (Commission File Number) |
95-2860434 (IRS Employer Identification No.) |
| 5777 W. Century Blvd, Suite 1285, Los Angeles, California |
90045 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant's telephone number, including area code: (310) 258-5000
Item 9. Regulation FD Disclosure
The following information is furnished pursuant to Item 9, "Regulation FD Disclosure" and Item 12, "Disclosure of Results of Operations and Financial Condition."
On May 15, 2003, CompuMed, Inc. ("CompuMed") issued a press release setting forth CompuMed's second-quarter 2003 earnings. A copy of CompuMed's press release is attached hereto as Exhibit (99) and hereby incorporated by reference.
Exhibit Index
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| CompuMed, Inc. | |||
By: |
/s/ JOHN G. MCLAUGHLIN John G. McLaughlin President and Chief Executive Officer |
||
Date: May 15, 2003